Evidence map›Paper›PMID 36059452›Full record

ReviewFrontiers in immunology2022

Host-microbiota interactions shaping T-cell response and tolerance in type 1 diabetes.

Shubhabrata Majumdar, Yong Lin, Matthew L Bettini

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Review
  3. Diabetes and gut microbiome.Frontiers in microbiology · 2024
    Review
  4. Article
  5. International journal of molecular sciences · 2023
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Shubhabrata MajumdarImmunology Graduate Program, Baylor College of Medicine, Houston, TX, United States.
Yong LinImmunology Graduate Program, Baylor College of Medicine, Houston, TX, United States.
Matthew L BettiniDepartment of Pathology, University of Utah, Salt Lake City, UT, United States.
University of Utah · USBaylor College of Medicine · US

Funding

Early life regulation of microbiota specific thymic T cell developmentR01AI173406 · NIAID · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Matthew Bettini, GRETCHEN E DIEHL · 2023 to 2026
$3.3M
Self-Reactive T Cell Development in Type 1 DiabetesR01DK114456 · NIDDK · UNIVERSITY OF UTAH · PI BETTINI, MATTHEW · 2018 to 2022
$1.9M
MICROBIOTA SPECIFIC T CELL SELECTIONR01AI136963 · NIAID · UNIVERSITY OF UTAH · PI BETTINI, MATTHEW · 2019 to 2023
$1.9M
NIAID NIH HHS R01 AI136963NIAID NIH HHS R01 AI173406NIDDK NIH HHS R01 DK114456
6 · The paper itself

Abstract

Type-1 Diabetes (T1D) is a complex polygenic autoimmune disorder involving T-cell driven beta-cell destruction leading to hyperglycemia. There is no cure for T1D and patients rely on exogenous insulin administration for disease management. T1D is associated with specific disease susceptible alleles. However, the predisposition to disease development is not solely predicted by them. This is best exemplified by the observation that a monozygotic twin has just a 35% chance of developing T1D after their twin's diagnosis. This makes a strong case for environmental triggers playing an important role in T1D incidence. Multiple studies indicate that commensal gut microbiota and environmental factors that alter their composition might exacerbate or protect against T1D onset. In this review, we discuss recent literature highlighting microbial species associated with T1D. We explore mechanistic studies which propose how some of these microbial species can modulate adaptive immune responses in T1D, with an emphasis on T-cell responses. We cover topics ranging from gut-thymus and gut-pancreas communication, microbial regulation of peripheral tolerance, to molecular mimicry of islet antigens by microbial peptides. In light of the accumulating evidence on commensal influences in neonatal thymocyte development, we also speculate on the link between molecular mimicry and thymic selection in the context of T1D pathogenesis. Finally, we explore how these observations could inform future therapeutic approaches in this disease.

Indexed as

Autoimmune DiseasesDiabetes Mellitus, Type 1Gastrointestinal MicrobiomeHumansImmune ToleranceInfant, NewbornInsulinInsulinmicrobiotamimicryT1D (type 1 diabetes)T-cellTh-17toleranceTreg cells

Identifiers

PMID36059452
PMCPMC9434376
OpenAlexW4292237642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.